Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer
NCT00428766
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Epithelial Ovarian Cancer
Interventions
DRUG:
MORAb-003
Sponsor
Morphotek